Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
CYCLOOXYGENASES 1 AND 2
19982.3k citationsJohn R. Vane, Y.S. Bakhle et al.The Annual Review of Pharmacology and Toxicologyprofile →
The mechanism of action of aspirin
2003896 citationsJohn R. Vane, R M BottingThrombosis Researchprofile →
New insights into the mode of action of anti-inflammatory drugs
1995690 citationsJohn R. Vane, R M BottingInflammation Researchprofile →
Anti-inflammatory drugs and their mechanism of action
1998602 citationsJohn R. Vane, R M BottingInflammation Researchprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of R M Botting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R M Botting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R M Botting more than expected).
This network shows the impact of papers produced by R M Botting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R M Botting. The network helps show where R M Botting may publish in the future.
Co-authorship network of co-authors of R M Botting
This figure shows the co-authorship network connecting the top 25 collaborators of R M Botting.
A scholar is included among the top collaborators of R M Botting based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R M Botting. R M Botting is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Botting, R M. (2006). Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.. PubMed. 57 Suppl 5. 113–24.156 indexed citations
2.
Vane, John R. & R M Botting. (2003). The mechanism of action of aspirin. Thrombosis Research. 110(5-6). 255–258.896 indexed citations breakdown →
3.
Vane, John R. & R M Botting. (1998). Anti-inflammatory drugs and their mechanism of action. Inflammation Research. 47(0). 78–87.602 indexed citations breakdown →
4.
Vane, John R. & R M Botting. (1998). Mechanism of action of antiinflammatory drugs.. PubMed. 20(1). 3–15.226 indexed citations
5.
Vane, John R., Y.S. Bakhle, & R M Botting. (1998). CYCLOOXYGENASES 1 AND 2. The Annual Review of Pharmacology and Toxicology. 38(1). 97–120.2332 indexed citations breakdown →
Vane, John R. & R M Botting. (1995). New insights into the mode of action of anti-inflammatory drugs. Inflammation Research. 44(1). 1–10.690 indexed citations breakdown →
10.
Vane, John R. & R M Botting. (1995). A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2).. PubMed. 23. 41–8.84 indexed citations
11.
Vane, John R., R M Botting, & Paul M. Vanhoutte. (1995). Up-to-Date on Endothelins. Journal of Cardiovascular Pharmacology. 26. S1–S1.4 indexed citations
12.
Vane, John R. & R M Botting. (1994). Mediators from the endothelial cell and their participation in inflammation.. PubMed. 16(1). 19–49.11 indexed citations
13.
Vane, J. R. & R M Botting. (1993). Control of the circulation by chemical mediators from the endothelium. 44(2).1 indexed citations
14.
Vane, John R. & R M Botting. (1993). Formation by the endothelium of prostacyclin, nitric oxide and endothelin.. PubMed. 6(1-3). 395–404.26 indexed citations
15.
Vane, John R. & R M Botting. (1992). Secretory functions of the vascular endothelium.. PubMed. 43(3). 195–207.32 indexed citations
16.
Vane, John R. & R M Botting. (1992). The role of chemical mediators released by the endothelium in the control of the cardiovascular system.. PubMed. 14(2). 55–64.11 indexed citations
17.
Vane, John R., R.J. Flower, & R M Botting. (1990). History of aspirin and its mechanism of action.. PubMed. 21(12 Suppl). IV12–23.124 indexed citations
18.
Änggård, Erik, R M Botting, & John R. Vane. (1990). Endothelins. Journal of Vascular Research. 27(2-5). 269–281.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.